Product Description

The global market for life sciences and analytical instruments increased from $34.80 billion in 2016 to $48.48 billion by 2021. The last 5-6 years have been predominantly eventful for instrument companies with major mergers and acquisitions, partnerships, new product launches, and other business developments. With rising government spending on pharmaceutical R&D in emerging nations, increasing life science research and development expenditure, progressing drug discovery and clinical diagnostics field, technological advancements, emerging applications, growing aging populations, rising prevalence of chronic diseases, and changing demographics;numerous industry participants reported record sales primarily driven by the robust growth in emerging countries such as China, India, and Brazil. The increase in number of biotechnology firms worldwide, advances in life science research and technology innovations with human genome mapping, and emergence of proteomics have enabled industry growth; as such high-end research projects require quality instruments with high throughput capacity are fueling the life Science and analytical instrumentation market further. However, presence of alternative technologies and high cost of instruments are some of the key factors hampering the growth of this market.

The global life science and analytical instruments market is mainly segmented by product, end-user, and geography. Spectroscopy segment commanded the largest share in the global life science and analytical instruments market, followed by separation techniques such as liquid and gas chromatography. The comprehensive end-user analysis is provided in the report for each technology. The market is further segmented by geography into four major continents namely, North America, Europe, Asia-Pacific, and Rest of the World (RoW). These regions are further analyzed at a country level to provide the market size and forecast for each segment and sub-segment of the market in various countries across the globe. North America and Europe have been in the forefront of acknowledging the need for life science and analytical instruments in biopharmaceuticals and pharmaceuticals, followed by Asia-Pacific, Latin America, and Middle East & Africa.

The U.S. accounted for the largest share in the global life science and analytical instruments market in 2015. The large share of this region can be attributed to the operating performance within an evolving regulatory and risk environment, ongoing pricing and cost pressures, and adoption of new business models enabled by scientific and technology advances in this country. On the other hand, emerging markets in Asia Pacific and Latin America region provides significant opportunities for the growth of this market as a result of many technological and healthcare reforms in these regions with improved economic conditions and positive approach of the government towards the life science and biotechnology sector.

The leading 40-50 life science and analytical instruments companies accounted for more than 70% share of the global market. These leading players further aims to expand in the global market through various mergers and acquisitions. key players in the global life science and analytical instrumentation market are Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), PerkinElmer, Inc. (U.S.), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (U.S.), and Waters Corporation (U.S.).

Key questions answered in the report-

Which are the high growth market segments in terms of life science and analytical instrumentation technologies,end users,regions, and countries?

What is the historical market for life science and analytical instruments across the globe?

What are the market forecasts and estimates from the period 2016-2021?

What are the major drivers, restrains, threats, and opportunities in the global life science and analytical instruments market?

What are the burning issues of the global life science and analytical instruments market?

Who are the major players in the global life science and analytical instruments market and what share of the market do they hold?

Who are the major players in various regions (North America, APAC, Europe, Latin America, and Middle East & Africa) and what share of the market do they hold?

What are the competitive landscapes and who are the market leaders by sub-region in the global life science and analytical instruments market?

What are the recent developments in the global life science and analytical instruments market?

What are the different strategies adopted by the major players in the global life science and analytical instruments market?

What are the geographical trends and high growth regions/ countries?

TABLE OF CONTENT

1. Introduction to Global Life Science and Analytical Instruments Market

1.1 Market Ecosystem

1.1.1 Market By Technology

1.1.2 Market By End Users

1.2 Report Elucidation

1.3 Market Buzz and Foreground

1.4 Research Methodology

1.4.1 Secondary Research

1.4.2 Primary Research

1.4.3 Market Analytics

2. Executive Summary

3. Key Market Insights

3.1 Drivers

3.1.1 Government initiatives to drive the global life science and analytical instruments market

3.1.2 Increasing investments and funding for life sciences, pharmaceutical, and biotechnology research

3.1.3 Increasing clinical capabilities

3.1.4 Expansions in the various application areas

3.1.5 Agreements with academic institutes and research

3.2 Restraints

3.2.1 High cost of instruments

3.2.2 Growing market consolidation

3.2.3 Lack of Funding

3.3 Opportunities

3.3.1 Growing proteomics market

3.3.2 Growing Investments in the Personalized Medicine

3.3.3 Emerging markets

3.3.4 Growing data analysis and management systems Market

3.4 Impact Analysis of various market dynamics

3.5 Market Share Analysis

4. Global Life Science and Analytical Instruments Market- By Technology

4.1 Chromatography

4.1.1 HPLC

4.1.2 Gas Chromatography

4.1.3 Low Pressure Liquid Chromatography

4.1.4 Ion Chromatography

4.1.5 Flash Chromatography

4.1.6 Thin Layer Chromatography

4.1.7 Supercritical Fluid Chromatography

4.2 Electrophoresis

4.2.1 Capillary Electrophoresis

4.2.2 Gel Electrophoresis

4.3 Microarrays

4.3.1 DNA Array

4.3.2 Protein Microarray

4.3.3 Cell Array

4.3.4 Tissu Array

4.3.5 Others

4.4 DNA Sequencer & Amplifiers

4.4.1 DNA Sequencers

4.4.2 DNA Amplifiers

4.4.2.1 Thermal Cyclers

4.4.2.2 Real-Time PCR

4.4.2.3 Others

4.5 Flow Cytometry

4.5.1 Cell Based Flow Cytometers

4.5.2 Bead Based Cytometers

4.5.3 Others

4.6 Immunoassay Analyser

4.6.1 Enzyme Immunoassay

4.6.2 Fluorescence Immunoassay

4.6.3 Chemiluminescence Immunoassay

4.6.4 Radioimmunoassay

4.6.5 Nephelometric Immunoassay

4.7 Mass Spectrometry

4.7.1 Quadrupole LC/MS

4.7.2 Time of Flight LC/MS (Q-TOF & LC-TOF)

4.7.3 GC/MS

4.7.4 MALDI-TOF

4.7.5 FT/MS and Ion Trap LC/MS

4.7.6 Magnetic Sector MS

4.7.7 Portable and In-Field MS

4.8 Molecular Spectroscopy

4.8.1 UV/Vis Spectroscopy

4.8.2 Polarimeters and Refractometers

4.8.3 Ellipsometry

4.8.4 Color Measurement

4.8.5 Fluorescence & Luminescence

4.8.6 Near-Infrared Spectroscopy (NIR)

4.8.7 Infrared Spectroscopy (IR)

4.8.8 Raman Spectroscopy

4.8.9 Nuclear Magnetic Resonance (NMR)

4.9 Atomic Spectroscopy

4.9.1 Atomic Absorbance Spectroscopy (AA)

4.9.2 Arc/Spark Optical Emission Spectroscopy

4.9.3 ICP & Glow Discharge

4.9.4 Inductively Coupled Plasma

4.9.5 Inorganic Elemental Analysis

4.9.6 TOC & Other Sum Parameters

4.9.7 Organic Elemental Analysis

4.9.8 X-ray Diffraction (XRD)

4.9.9 X-ray Fluorescence (XRF)

4.10 Surface Science Techniques

4.10.1 Optical Microscopy

4.10.2 Confocal Microscopy

4.10.3 Electron Microscopy

4.10.4 Scanning Probe Microscopy

4.10.5 Surface Analyzers

4.11 Lab Automation

4.11.1 Microplate Readers

4.11.2 Automatic Liquid Handling

4.11.3 Robotics

4.11.4 Automated Storage and Retrieval Systems

4.11.5 Management Informatics (LIMS, ELN/LESand SDMS)

5. Global Life Science and Analytical Instruments Market- By End Users

Select License Type

Single User -

Multiple User -

Corporate User -

License Details

Single User:

With the help of Single User License, only an individual can use our report either electronically or online. The right to use of the report should be confined only to one authorized computer. Upon buying single user license, buyer must provide the names and email ids of the authorized users of this report.

Multi Users:

Multi-User license permits to access the report from five authorized computers. It does not permit you to share the report with other divisions and subsidiaries of the same company. Upon buying multi-user license, buyer must provide the names and email ids of the authorized users of this report.

Corporate User

With corporate use license, the complete or part of the content of the report can be shared or made available to other persons, other divisions and subsidiaries of same company. However, reproduction or redistribution of the report is prohibited without the prior permission of Meticulous Research.

Dating back from 1970’s, it is believed that use of barcode technology in various healthcare settings has reduced the medication errors and the cost incurred in rehabilitating the patient after the wrong treatment. The adoption of such advanced technologies in the healthcare sector will drastically enhance the operations of hospitals or other healthcare systems.

According to the Journal of Patient Safety, around 400,000 deaths occur each year in the U.S. only. It also reveals that each year preventable adverse events (PAEs) lead to the death of 210,000-400,000 patients who seek care at a hospital.

Corn is the leading source of starch extraction. The corn plant has large capacity for efficiently converting large amounts of radiant energy from the sun into stable chemical energy. This energy is stored as cellulose, oil, and starch in the corn plant and in the corn kernel. The corn plant is also one of nature's greatest multipliers.

Pharmaceutical industry has grown in leaps and bounds during the last three to four decades. Initial emphasis on validation of tablets started across the industry globally sometime in late sixties or early seventies.